HealthCor Management, L.P. Buys Bristol-Myers Squibb Co, AmerisourceBergen Corp, Centene Corp, Sells Regeneron Pharmaceuticals Inc, Humana Inc, Danaher Corp

New York, NY, based Investment company HealthCor Management, L.P. (Current Portfolio) buys Bristol-Myers Squibb Co, AmerisourceBergen Corp, Centene Corp, Jazz Pharmaceuticals PLC, McKesson Corp, sells Regeneron Pharmaceuticals Inc, Humana Inc, Danaher Corp, Thermo Fisher Scientific Inc, CVS Health Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, HealthCor Management, L.P.. As of 2021Q3, HealthCor Management, L.P. owns 73 stocks with a total value of $2.3 billion. These are the details of the buys and sells.

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of HealthCor Management, L.P.
  1. Bristol-Myers Squibb Co (BMY) - 3,584,160 shares, 9.15% of the total portfolio. Shares added by 143.10%
  2. Horizon Therapeutics PLC (HZNP) - 1,278,228 shares, 6.04% of the total portfolio. Shares added by 3.50%
  3. Biogen Inc (BIIB) - 466,830 shares, 5.70% of the total portfolio. Shares added by 37.59%
  4. AmerisourceBergen Corp (ABC) - 896,680 shares, 4.62% of the total portfolio. Shares added by 239.21%
  5. Petco Health and Wellness Co Inc (WOOF) - 4,944,450 shares, 4.50% of the total portfolio.
New Purchase: Centene Corp (CNC)

HealthCor Management, L.P. initiated holding in Centene Corp. The purchase prices were between $59.73 and $74.7, with an estimated average price of $66.89. The stock is now traded at around $74.980000. The impact to a portfolio due to this purchase was 2.64%. The holding were 982,630 shares as of 2021-09-30.

New Purchase: Jazz Pharmaceuticals PLC (JAZZ)

HealthCor Management, L.P. initiated holding in Jazz Pharmaceuticals PLC. The purchase prices were between $128.64 and $184.79, with an estimated average price of $151.34. The stock is now traded at around $137.960000. The impact to a portfolio due to this purchase was 2.59%. The holding were 460,790 shares as of 2021-09-30.

New Purchase: Cigna Corp (CI)

HealthCor Management, L.P. initiated holding in Cigna Corp. The purchase prices were between $200.16 and $238.3, with an estimated average price of $217.75. The stock is now traded at around $217.760000. The impact to a portfolio due to this purchase was 1.83%. The holding were 211,780 shares as of 2021-09-30.

New Purchase: Cano Health Inc (CANO)

HealthCor Management, L.P. initiated holding in Cano Health Inc. The purchase prices were between $9.66 and $15.44, with an estimated average price of $12.14. The stock is now traded at around $11.010000. The impact to a portfolio due to this purchase was 1.51%. The holding were 2,754,730 shares as of 2021-09-30.

New Purchase: Becton, Dickinson and Co (BDX)

HealthCor Management, L.P. initiated holding in Becton, Dickinson and Co. The purchase prices were between $238.54 and $262.88, with an estimated average price of $251.45. The stock is now traded at around $244.110000. The impact to a portfolio due to this purchase was 1.49%. The holding were 140,540 shares as of 2021-09-30.

New Purchase: Fate Therapeutics Inc (FATE)

HealthCor Management, L.P. initiated holding in Fate Therapeutics Inc. The purchase prices were between $59.27 and $95.73, with an estimated average price of $78.58. The stock is now traded at around $55.490000. The impact to a portfolio due to this purchase was 0.33%. The holding were 128,450 shares as of 2021-09-30.

Added: Bristol-Myers Squibb Co (BMY)

HealthCor Management, L.P. added to a holding in Bristol-Myers Squibb Co by 143.10%. The purchase prices were between $59.17 and $69.31, with an estimated average price of $65.87. The stock is now traded at around $59.100000. The impact to a portfolio due to this purchase was 5.39%. The holding were 3,584,160 shares as of 2021-09-30.

Added: AmerisourceBergen Corp (ABC)

HealthCor Management, L.P. added to a holding in AmerisourceBergen Corp by 239.21%. The purchase prices were between $112.6 and $125.8, with an estimated average price of $120.16. The stock is now traded at around $123.860000. The impact to a portfolio due to this purchase was 3.26%. The holding were 896,680 shares as of 2021-09-30.

Added: McKesson Corp (MCK)

HealthCor Management, L.P. added to a holding in McKesson Corp by 175.24%. The purchase prices were between $188.42 and $208.66, with an estimated average price of $199.89. The stock is now traded at around $220.610000. The impact to a portfolio due to this purchase was 2.43%. The holding were 442,470 shares as of 2021-09-30.

Added: Tenet Healthcare Corp (THC)

HealthCor Management, L.P. added to a holding in Tenet Healthcare Corp by 188.22%. The purchase prices were between $64.66 and $75.98, with an estimated average price of $70.97. The stock is now traded at around $79.700000. The impact to a portfolio due to this purchase was 2.03%. The holding were 1,084,240 shares as of 2021-09-30.

Added: Envista Holdings Corp (NVST)

HealthCor Management, L.P. added to a holding in Envista Holdings Corp by 92.99%. The purchase prices were between $39.75 and $44.09, with an estimated average price of $42.21. The stock is now traded at around $42.700000. The impact to a portfolio due to this purchase was 1.96%. The holding were 2,249,972 shares as of 2021-09-30.

Added: LivaNova PLC (LIVN)

HealthCor Management, L.P. added to a holding in LivaNova PLC by 421.72%. The purchase prices were between $76.02 and $88.62, with an estimated average price of $82.24. The stock is now traded at around $86.010000. The impact to a portfolio due to this purchase was 1.8%. The holding were 652,150 shares as of 2021-09-30.

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

HealthCor Management, L.P. sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $574.03 and $680.96, with an estimated average price of $621.14.

Sold Out: Humana Inc (HUM)

HealthCor Management, L.P. sold out a holding in Humana Inc. The sale prices were between $389.15 and $471.22, with an estimated average price of $424.73.

Sold Out: Danaher Corp (DHR)

HealthCor Management, L.P. sold out a holding in Danaher Corp. The sale prices were between $272.21 and $332.43, with an estimated average price of $306.96.

Sold Out: Thermo Fisher Scientific Inc (TMO)

HealthCor Management, L.P. sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $509.53 and $609.78, with an estimated average price of $548.6.

Sold Out: Veeva Systems Inc (VEEV)

HealthCor Management, L.P. sold out a holding in Veeva Systems Inc. The sale prices were between $282.94 and $341, with an estimated average price of $317.34.

Sold Out: Amgen Inc (AMGN)

HealthCor Management, L.P. sold out a holding in Amgen Inc. The sale prices were between $212.27 and $248.7, with an estimated average price of $230.39.



Here is the complete portfolio of HealthCor Management, L.P.. Also check out:

1. HealthCor Management, L.P.'s Undervalued Stocks
2. HealthCor Management, L.P.'s Top Growth Companies, and
3. HealthCor Management, L.P.'s High Yield stocks
4. Stocks that HealthCor Management, L.P. keeps buying